porozendoОстеопороз и остеопатииOsteoporosis and Bone Diseases2072-26802311-0716Endocrinology Research Centreporozendo-12940Research ArticleНовостиNewsПресс-релиз с конгресса Американского общества изучения костного и минерального метаболизма ASBMR 2021 Annual MeetingREPORT ON THE AMERICAN SOCIETY FOR THE BONE AND MINERAL RESEARCH CONGRESS - ASBMR 2021 ANNUAL MEETINGЖуковА. Ю.ZhukovA. Y.

Москва

zhukovartem@yahoo.comПоваляеваА. А.PovaliaevaA. A.

Москва

ФГБУ Национальный медицинский исследовательский центр эндокринологии» Минздрава РоссииРоссия2021020420222443940Copyright © Жуков А.Ю., Поваляева А.А., 20222022Жуков А.Ю., Поваляева А.А.Zhukov A.Y., Povaliaeva A.A.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.osteo-endojournals.ru/jour/article/view/12940

Американское общество изучения костного и минерального метаболизма (англ. American Society for Bone and Mineral Research, ASBMR) — одно из самых крупных и авторитетных мировых профессиональных сообществ, деятельность которого посвящена проблемам метаболических заболеваний скелета и патологии минерального обмена. Ежегодно проходит конгресс общества ASBMR Annual Meeting, в котором участвуют тысячи специалистов со всего мира. В 2021 г. мероприятие прошло в городе Сан-Диего, штат Калифорния, США, с 1 по 4 октября в гибридном формате: очно и онлайн. Конгресс освещал как фундаментальные, так и клинические вопросы метаболических заболеваний скелета и минерального обмена. Далее мы представим краткий обзор основных новостей клинической части мероприятия.

.

Участие авторов в конгрессе поддержано Российским научным фондом (проект 19-15-00243)ReferencesWhittier D, Samelson E, Hannan M, et al. A fracture risk assessment tool for high resolution peripheral quantitative computed tomography: The Bone Microarchitecture International Consortium (BoMIC).Whittier D, Samelson E, Hannan M, et al. A fracture risk assessment tool for high resolution peripheral quantitative computed tomography: The Bone Microarchitecture International Consortium (BoMIC).Alajlouni D, Tran T, Bliuc D, et al. Muscle Strength and Physical Performance Improve Fracture Risk Prediction in Men beyond Garvan and FRAX: The Osteoporotic Fractures in Men (MrOS) Study.Alajlouni D, Tran T, Bliuc D, et al. Muscle Strength and Physical Performance Improve Fracture Risk Prediction in Men beyond Garvan and FRAX: The Osteoporotic Fractures in Men (MrOS) Study.Damm T, Schmarje L, Koser N, et al. Artificial intelligence-driven hip fracture prediction based on pelvic radiographs exceeds performance of DXA: the “Study of Osteoporotic Fractures” (SOF).Damm T, Schmarje L, Koser N, et al. Artificial intelligence-driven hip fracture prediction based on pelvic radiographs exceeds performance of DXA: the “Study of Osteoporotic Fractures” (SOF).Tripto-Shkolnik L, Szalat A, Tsvetov G, et al. A Six-month Phase 2 Study of Oral PTH in Postmenopausal Women with Low Bone Mass. An Interim Three-Month Analysis.Tripto-Shkolnik L, Szalat A, Tsvetov G, et al. A Six-month Phase 2 Study of Oral PTH in Postmenopausal Women with Low Bone Mass. An Interim Three-Month Analysis.Galitzer H, Santora A, Tripto-Shkolnik L, et al. A Six-month Phase 2 Study of Oral PTH in Postmenopausal Women with Low Bone Mass 6 Month Bone Mineral Density (BMD) results.Galitzer H, Santora A, Tripto-Shkolnik L, et al. A Six-month Phase 2 Study of Oral PTH in Postmenopausal Women with Low Bone Mass 6 Month Bone Mineral Density (BMD) results.Kistler-Fischbacher M, Yong JS, Weeks BK, Beck BR. Targeted high-intensity exercise with and without antiresorptive medication to increase bone strength and reduce fracture risk in postmenopausal women: the MEDEX-OP trial.Kistler-Fischbacher M, Yong JS, Weeks BK, Beck BR. Targeted high-intensity exercise with and without antiresorptive medication to increase bone strength and reduce fracture risk in postmenopausal women: the MEDEX-OP trial.Bilek L, Flores L, Kupzyk K, et al. Bone Loading Exercises Versus Risedronate for the Prevention of Osteoporosis in Postmenopausal Women with Low Bone Mass.Bilek L, Flores L, Kupzyk K, et al. Bone Loading Exercises Versus Risedronate for the Prevention of Osteoporosis in Postmenopausal Women with Low Bone Mass.Eastell R, Vittinghoff E, Lui L-Y, et al. Validation of the Surrogate Threshold Effect as a Method to Implement Change in BMD as a Surrogate Endpoint for Fracture Outcomes: the FNIH-ASBMR SABRE Project.Eastell R, Vittinghoff E, Lui L-Y, et al. Validation of the Surrogate Threshold Effect as a Method to Implement Change in BMD as a Surrogate Endpoint for Fracture Outcomes: the FNIH-ASBMR SABRE Project.

The authors declare that there are no conflicts of interest present.